Actavis’ newly appointed senior management team effective after Allergan acquisition

Actavis announced that the company’s newly appointed management team will become effective immediately after the anticipated successful close of the Allergan acquisition in the second quarter of 2015, according to a press release.Brent Saunders will continue to serve as CEO, president and member of the board of directors, and Paul Bisaro will continue as executive chairman of the board of directors, the release said.